ClinConnect ClinConnect Logo
Search / Trial NCT07052019

Pain Perception and Anxiety With Virtual Reality vs Tell-Show-Do in Children With MIH

Launched by CAIRO UNIVERSITY · Jun 26, 2025

Trial Information

Current as of July 25, 2025

Not yet recruiting

Keywords

Molar Incisor Hypomineralization Mih Virtual Reality Behavioral Pain Anxiety

ClinConnect Summary

This clinical trial is looking at how two different methods—Virtual Reality (VR) and a traditional approach called Tell-Show-Do (TSD)—affect pain and anxiety in children aged 6 to 12 who have a dental condition called Molar Incisor Hypomineralization (MIH). MIH affects the first permanent molars and can make these teeth more sensitive and prone to cavities. The study will compare whether using VR as a distraction during dental treatment helps children feel less pain and anxiety compared to the usual method where the dentist explains and shows the procedure before doing it.

Children who might join the study need to be between 6 and 12 years old, have two affected first molars that need simple cavity treatment, and be willing to cooperate during the dental visit. Children with more complicated dental problems, previous treatments on these teeth, or certain health or behavioral conditions would not be eligible. If a child takes part, they can expect to experience both VR distraction and the Tell-Show-Do method during separate dental visits, so the researchers can see which one works better to make the treatment more comfortable. This study has not started recruiting participants yet, but it aims to find ways to help children with MIH feel less scared and in pain during dental care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children aged between 6-12 years.
  • Patients with two First Permanent molars diagnosed with MIH indicated for class I cavities.
  • A cooperative and compliant patient/ parent.
  • Patients not allergic to medicaments necessary to complete the procedure.
  • Patients with no history of chronic systemic diseases.
  • Exclusion Criteria:
  • MIH-affected molars require apexogenesis, apexification, regeneration or RCT.
  • Non-restorable tooth.
  • Previous restorative treatment.
  • Periodontally affected.
  • Children having systemic disease, an emotional behavioural or learning disorder.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Giza, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported